Osteoclastogenesis and osteoclast activation in dialysis-related amyloid osteopathy

American Journal of Kidney Diseases

Volumn 38, Issue 4 SUPPL. 1, 2001, Pages

  Kazama, J J ^a   Maruyama, H ^a   Gejyo, F ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Bone cyst; Destructive spondyloarthropathy (DSA); Dialysis related amyloid osteopathy (DRAO); Osteoclast; Receptor activator of nuclear factor KB ligand osteoprotegerin ligand (RANKL OPFGL)

Indexed keywords

CYTOKINE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

AMYLOIDOSIS; BONE DISEASE; BONE RADIOGRAPHY; CONFERENCE PAPER; DIALYSIS; DIALYSIS RELATED AMYLOID OSTEOPATHY; HISTOLOGY; HUMAN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; SPONDYLOARTHROPATHY;

EID: 0034817424     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.27427     Document Type: Conference Paper

References (19)

1. Extraskeletal problems and amyloid
2. Pathological fractures in patients who have amyloidosis associated with dialysis. A report of five cases
3. Bone cyst in the cervical spine due to secondary amyloidosis. A case report
4. Clinical studies of destructive spondyloarthropathy in long-term hemodialysis patients
5. Cervical discs are most susceptible to beta2-microglobulin amyloid deposition in the vertebral column
6. Pathologic features of spinal disorders in patients treated with long-term hemodialysis
7. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
8. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
9. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
10. Activation of osteoclasts by interleukin-1: Divergent responsiveness in osteoclasts formed in vivo and in vitro
11. The mechanism of coupling: A role for the vasculature
12. Bone cell interactions and regulation by inflammatory mediators
13. Role of macrophages in β2-microglobulin-related dialysis amyloidosis
14. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles
15. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-β2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis
16. 131I-β2-microglobulin in patients with dialysis related amyloidosis
17. Reduction of circulating beta2-microglobulin level for the treatment of dialysis related amyloidosis
18. Therapeutic approaches to bone diseases
19. 131I-β2-microglobulin scintigraphy in patients with dialysis amyloidosis